You are here

AusPAR: Cemiplimab

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

9 November 2020
AusPAR Details
AusPAR
Active Ingredient
Cemiplimab
Product Name
Libtayo
Sponsor
Sanofi-Aventis Australia Pty Ltd
Submission Number
PM-2019-03270-1-4
Submission Type
New biological entity
Decision
Approved for provisional registration
AusPAR Date
2 November 2020
Publication Date

9 November 2020